✦ LIBER ✦

A phase I study of a HER2/neu bispecific antibody with granulocyte-colony-stimulating factor in patients with metastatic breast cancer that overexpresses HER2/neu

✍ Scribed by V. Pullarkat; Y. Deo; J. Link; L. Spears; V. Marty; R. Curnow; S. Groshen; C. Gee; J. S. Weber

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A virosomal formulated Her-2/neu multi-p

✍ Ursula Wiedermann; C. Wiltschke; J. Jasinska; M. Kundi; R. Zurbriggen; E. Garner 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 321 KB

Clinical evaluation of the bispecific an

✍ H. H. van Ojik; R. Repp; Gerard Groenewegen; Thomas Valerius; Jan G. J. van de W 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 332 KB

A phase II study of trastuzumab and cape

✍ Daigo Yamamoto; Satoru Iwase; Kaoru Kitamura; Hiroki Odagiri; Chizuko Yamamoto; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 232 KB

Phase II study of mitoxantrone by 14-day

✍ Lajos Pusztai; Frankie A. Holmes; Giuseppe Fraschini; Gabriel N. Hortobagyi 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 142 KB

A phase-I trial of the epidermal growth

✍ Matthew G. Fury; Allan Lipton; Katherine M. Smith; Corinne B. Winston; David G. 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 377 KB

A phase I study of anti-GD3 ganglioside

✍ Lori M. Minasian; Tzy Jyun Yao; Thomas A. Steffens; David A. Scheinberg; Linda W 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 647 KB